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Aujeszky's disease (AD) causes heavy mortalities among young pigs and 
great economic loss in pig farms. Despite vaccination, frequent sporadic outbreaks 
have been reported in different parts of Malaysia. The extent of economic loss 
caused by the disease is not clearly known since no detailed study has been 
conducted to measure the prevalence and impact of the disease in pig production. 
This study reports the results of a nationwide sero-epidemiological survey of the 
disease and attempts to determine its status among the pig population in Malaysia. 
It also examines some control measures that can be taken to reduce the prevalence 
of the disease. 
A commercial glycoprotein E (gE) negative enzyme-linked immunosorbent 
assay (ELISA) kit was used in the serological survey. The kit could detect 
antibodies against gE of AD virus which is present in the field strain of the virus 
xv 
but not in the vaccine strain. In addition, it could test large number of serum 
samples in a short period of time. The ELISA was evaluated with respect to the 
serum neutralization test (SNT) which was used as the standard reference test. The 
kappa value between the ELISA SIN values and SNT titres were found to be 0.95, 
indicating that there was a good agreement between the ELISA and SNT. It was 
also found that the ELISA had a high index of sensitivity (96.25%) and specificity 
(98.75%) comparable to SNT. The investigations therefore, confirmed the 
suitability of the ELISA as a practical alternative to the SNT as a mass screening 
test for the serodiagnosis of AD. 
To investigate the sero-epidemiology of AD in pigs in the country, a total of 
2985 blood samples were collected from 100 pig farms in six major pig producing 
states of Malaysia and screened for gE antibodies against AD virus using the gE 
ELISA kit. Collectively, the pig population of these farms accounted for about 20.3 
per cent of the pig population in West Malaysia. A widespread occurrence of the 
infection in the pig population in Malaysia was detected due to the high percentage 
(55.4%) of serological reactors in 84% of the farms surveyed. The study confirmed 
that AD is highly prevalent among pig herds in Malaysia and that vaccination on an 
individual herd basis did not minimize the spread of the virus among breeding pigs 
in enzuulicaHy infected, high pig density regions. To reduce the prevalence of AD, 
vaccination in the finishing section of farrow-to-finish herds may be warranted 
using more effective vaccines. In addition, an effective vaccination programme and 
a better biosecurity management system in the farms may be necessary to reduce 
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the prevalence of the disease to a point where an eradication programme against 
AD could be initiated in Malaysia. 
The immune response in pigs against a disease has been known to 
be maximum when vaccination is given at the time of lowest maternal antibody 
level. To determine the optimum time of vaccination against AD in piglets in an 
endemic farm, blood samples were collected randomly from pigs of ages 4 to 16 
weeks. The blood samples were tested for antibodies against AD by the SN test. It 
was found that maternal antibodies against AD persisted in pigs up to 14 weeks of 
age. Therefore, earlier vaccination may not be effective as the maternal antibodies 
may interfere with the vaccine virus. In another investigation, it was found that 
piglets born from parity three dams had higher levels of maternal antibodies against 
AD than piglets born of parity one sows. Vaccination for piglets born of dams of 
higher parity may therefore, be preferably at a later date than piglets born from 
dams of lower parity. 
A study using a live and an inactivated AD vaccine was conducted in four­
week-old pigs in a commercial farm to determine the effect -of maternally derived 
antibodies on vaccination against endemic AD. It was found that maternally 
derived antibodies did not have a profound effect on vaccination against AD in 
four-week-old piglets. Furthermore, there were less economic losses in terms of 
mortality and body weight in vaccinated pigs as cbt'npared to non-vaccinated 
animals. Economic losses were lowest in pigs vaccinated with the live vaccine. 
Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia bagi 
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Penyakit Aujeszky (AD) menyebabkan kadar kematian yang tinggi di 
kalangan anak babi dan mengakibatkan kerugian yang amat besar dalam 
petemakaan babi. Walaupun pemvaksinan dijalankan, penyakit ini masih tetjadi di 
beberapa kawasan di Malaysia. Kerugian ekonomi yang disebabkan oleh penyakit 
ini kurang jelas kerana sehingga kini tidak ada suatu kajian terperinci mengenai 
prevalens dan impak penyakit tersebut kepada industri babi di Malaysia. Kajian ini 
melaporkan hasil penyelidikan sero-epidemiologi AD di Malaysia dan bertujuan 
untuk menentukan status penyakit tersebut. Ia juga mengkaji beberapa langkah 
pengawalan yang dapat diambil untuk mengurangkan prevalens penyakit tersebut. 
Dalam kajian ini, ujian assai enzim-gabung immunosorbent (ELISA) yang 
berkomersial telah digunakan. Ujian ini dapat mengesan antibodi terhadap 
glycoproten E (gE) yang didapati di dalam virus strain lapangan AD tetapi yang 
tidak didapati dalam virus strain vaksin. Dengan cara ini, seroprevalens antibodi 
strain lapangan AD dapat dikesan. Disamping itu, ujian ELISA ini juga dapat 
menguji sampel darah yang banyak dalam jangkamasa yang singkat. Ujian ELISA 
ini telah dinilai dengan menggunakan ujian peneutralian serum (SNT) sebagai ujian 
rujukan dan adalah didapati bahawa nilai perbandingan kappa (k) adalah 0.95. 
ELISA juga telah menunjukkan kepekaan (96.25%) dan pengkhususan (98.75%) 
yang tinggi berbanding dengan SNT. Oleh itu, ujian ELISA telah digunakan 
sebagai alternatif yang lebih praktikal untuk sero-diagnosis AD. 
Untuk mengkaji sero-epidemiologi AD dalam babi di Malaysia, sejumlah 
2985 sampel darah telah diambil dari seratus ladang babi dari enam buah negeri 
pengeluar terbesar di Malaysia dan diuji dengan ujian gE ELISA. Ladang-ladang 
babi ini dianggarkan mempunyai 20% dari jumlah babi di Malaysia Barat. Kajian 
ini telah menunjukkan bahawa 55.4% sampel darah babi dan 84% ladang babi yang 
dikaji mempunyai antibodi terhadap virus lapangan AD dan ini menunjukkan 
bahawa seroprevalen AD di Malaysia adalah tinggi sungguhpun pemvaksinan 
dijalankan dalam stok pembiak babi. Untuk mengurangkan prevalens AD, 
pemvaksinan dalam stok pengeluaran dengan vaksin yang lebih berkesan mungkin 
diperlukan. Disamping itu, program-program pemvaksinan dan pengurusan 
biosekuriti ladang yang lebih berkesan diperlukan untuk mengurangkan kadar 
prevalens penyakit ini sehingga penyakit ini dapat dibasmikan di Malaysia. 
Pemvaksinan babi pada umur di mana tahap antibodi pasif dari ibu adalah 
paling rendah telah dilaporkan memberi immuniti yang optima terhadap AD. Untuk 
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menentukan mas a yang paling sesuai bagi pemvaksinan terhadap AD, sampel 
darah telah diambil dari babi yang berumur empat hingga 16 minggu dari sebuah 
ladang AD yang endemik. Ujian SNT telah digunakan untuk mengesan antibodi 
AD dalam sampel darah ini dan didapati bahawa antibodi AD yang diberikan oleh 
ibu tidak dapat dikesan selepas umur babi yang melebihi dua belas minggu. Ini 
telah menunjukkan bahawa umur yang paling sesuai untuk menjalankan 
pemvaksinan AD pada anak babi diladang tersebut adalah pada umur minggu 
keempat-belas. Dalam kajian ini juga didapati bahawa anak babi yang dilahirkan 
oleh ibu yang telah beranak pada kali yang ketiga mempunyai tahap antibodi pasif 
yang lebih tinggi daripada anak babi yang dilahirkan oleh ibu dara. lni 
menunjukkan bahawa pengenalpastian kerapkalian ibu beranak juga penting untuk 
menentukan masa pemvaksinan. 
Antibodi dari ibu dilapurkan dapat mengurangkan keberkesanan 
pemvaksinan terhadap AD. Oleh itu, satu kajian telah dijalankan untuk mengkaji 
kesan antibodi ibu ke atas pemvaksinan AD dalam anak babi pada umur empat 
minggu. Kedua-dua vaksin hidup dan vaksin mati digunakan dalam kajian ini dan 
didapati bahawa antibodi dari ibu tidak mengurangkan keberkesanan pemvaksinan 
AD dengan ketara. Ia juga telah membuktikan bahawa dengan pemvaksinan, 
kerugian dalam ladang yang disebabkan oleh AD seperti kadar kematian dan 
tumbesaran badan yang rendah dapat dikurangkan. Kerugian ekonomi ini adalah 




Aujeszky's disease (AD) is a worldwide problem, causing death in many 
mammalian species and huge economical losses to the pig industry (OIE, 1996). The 
disease causes heavy mortalities among young pigs and great losses in the 
productivity of pig farms. It is caused by the suid herpes virus and depending on the 
age of the pig, the virus strain and the amount of virus infecting the animal, infection 
of swine could result in signs ranging from inapparent disease to death caused by 
infection of the respiratory tract or central nervous system (Wittman and 
Rziha,1989). Economic losses are mainly due to perinatal deaths, abortions, reduced 
fertility, reduced weight gains and respiratory problems in fattening pigs resulting in 
severe reduction in productivity (Gustafson, 1984). 
In Malaysia, despite vaccination, sporadic outbreaks of the disease have been 
reported frequently in different parts of the country (Too, 1995). It has emerged to 
be one of the most important diseases affecting swine production and is the only 
other swine disease apart from classical swine fever against which vaccination is 
practised regularly in majority of the pig farms in Malaysia. The extent of loss in 




has been conducted to measure the prevalence and impact of the disease on pig 
production. Therefore, a study to determine the status of the disease in the country 
was required. 
The serum neutralization test (SNT) that is generally used in AD serological 
surveys has been found to be slow and laborious (Banks and Cartwright, 1983; 
Oirschot, 1991). The enzyme-linked immunosorbent assay (ELISA) which takes a 
shorter time to perform, is more sensitive and can be used for screening a large 
number of serum samples at a time (Durham et al., 1986; Oirschot et aI, 1986). 
Therefore, to conduct an extensive serological study of AD in the country, a 
commercial gE-negative ELISA kit was used as a practical alternative to the SNT. 
The ELISA was evaluated using the SNT as a standard reference test. The ELISA 
used in this study detected antibodies directed against glycoprotein E (gE) present in 
the field strain of AD virus. It does not detect antibodies due to vaccination by gE 
negative vaccines that are used widely in the country. 
To formulate a vaccination programme for the production stock in AD 
endemic farms, the persistence of maternal antibodies in the pigs need to be known 
so that the optimum time of vaccination against the disease could be determined. By 
conducting a vaccination programme at the proper time, maternal antibodies present 
in the piglets would therefore, not be able to interfere with the immune response due 
to vaccination. In this study, the duration of maternal protection against AD and the 
effect of dam parity on maternal immunity were thus determined. 
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It is a common practise in most Malaysian pig farms to carry out certain farm 
activities such as vaccination against classical swine fever (CSF) at 4-week­
weaning-age. At this age, the pigs are transferred to the weaner pens and therefore, 
vaccination is done simultaneously with minimum effort. If vaccination against AD 
was also to be conducted at the same time, there would be a need to determine the 
effect of maternally derived antibodies on the vaccine antigens that initiate an 
immune response. Therefore, a study was conducted to determine the degree of 
interference of these antibodies in AD vaccination in 4-week-old pigs and at the 
same time, to compare the efficacies of the live and inactivated vaccines in the 
presence of these antibodies. The following values were compared between the pigs 
vaccinated with the live AD vaccine, an inactivated AD vaccine and control pigs: (i) 
body conformation (ii) respiratory signs (iii) mortality of the pigs (iv) mean rise in 
SNT titres of the pigs and (v) mean daily weight gain of the pigs. 
Objectives of this study: 
1. To compare a commercial ELISA kit and SNT for the serodiagnosis of 
Aujeszky's disease. 
2. To determine the sero-epidemiology of AD in pigs in Malaysia. 
3. To determine the persistence of passively acquired antibodies to AD in an 
endemic farm so that the optimum time of vaccination against the disease could 
be determined. 
4. To determine the effect of maternally derived antibodies on vaccination against 
AD in four-week-old pigs. This study also assesses and compares the live and 
inactivated AD vaccine in improving the performance of passively immune 





Aujeszky's disease (AD) was first reported in 1902 by Aladar Aujeszky 
when he noticed the severe disease in cattle and dog in Hungary (Aujeszky, 1902). 
In North America, the disease was given the name mad itch due to the severe 
pruritus developed in cattle. The similarities of AD with the clinical signs of rabies 
led some workers to name the disease pseudorabies. However, it is in swine that AD 
has been found to be of greatest economic significance. 
Aetiology 
Aujeszky's disease virus belongs to the alphaherpesvirus family (Andrewes, 
1962). The pig is the natural host for AD virus, which accounts for its ability to be 
subclinically and latently infected (Shope, 1935; Mock et ai., 1981). Other common 
farm animals infected by the virus include cattle, sheep and goats. Dogs, cats and on 
rare occasions, horses can also be infected (Shope, 1935). The virus replicates and 
produces eosinophilic intranuclear inclusion bodies in a wide variety of mammalian 
and avian cell cultures (Reissig and Kaplan, 1962). The cytopathic effects (ePE) of 
AD viruses in cell cultures are seen as bright, shining, and spheroidal (Kaplan and 
Vatter, 1959). The viral envelope contains at least nine structural proteins with 
